Cited by 1,360Alcohol Consumption and Health EffectsCardiovascular Health and Risk FactorsLipoproteins and Cardiovascular Health

Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors

Open access
Rimm, E. B, Williams, P., Fosher, K., Criqui, M., Stampfer, M. J·1999·BMJ

Abstract

Abstract Objective: To summarise quantitatively the association between moderate alcohol intake and biological markers of risk of coronary heart disease and to predict how these changes would lower the risk. Design: Meta-analysis of all experimental studies that assessed the effects of moderate alcohol intake on concentrations of high density lipoprotein cholesterol, apolipoprotein A I, fibrinogen, triglycerides, and other biological markers previously found to be associated with risk of coronary heart disease. Participants: Men and women free of previous chronic disease and who were not dependent on alcohol Studies were included in which biomarkers were assessed before and after participants consumed up to 100 g of alcohol a day. Interventions: Alcohol as ethanol, beer, wine, or spirits. Main outcome measures: Changes in concentrations of high density lipoprotein cholesterol, apolipoprotein A I, Lp(a) lipoprotein, triglycerides, tissue type plasminogen activator activity, tissue type plasminogen activator antigen, insulin, and glucose after consuming an experimental dose of alcohol for 1 to 9 weeks; a shorter period was accepted for studies of change in concentrations of fibrinogen, factor VII, von Willebrand factor, tissue type plasminogen activator activity, and tissue type plasminogen activator antigen. Results: 61 data records were abstracted from 42 eligible studies with information on change in biological markers of risk of coronary heart disease. An experimental dose of 30 g of ethanol a day increased concentrations of high density lipoprotein cholesterol by 3.99 mg/dl (95% confidence interval 3.25 to 4.73), apolipoprotein A I by 8.82 mg/dl (7.79 to 9.86), and triglyceride by 5.69 mg/dl (2.49 to 8.89). Several haemostatic factors related to a thrombolytic profile were modestly affected by alcohol On the basis of published associations between these biomarkers and risk of coronary heart disease 30 g of alcohol a day would cause an estimated reduction of 24.7% in risk of coronary heart disease. Conclusions: Alcohol intake is causally related to lower risk of coronary heart disease through changes in lipids and haemostatic factors. Key messages Results from observational studies provide strong evidence that moderate alcohol intake lowers risk of coronary heart disease Short term trials of alcohol intake show significant changes in concentrations of lipids and clotting factors The changes in concentrations of high density lipoprotein cholesterol, fibrinogen, and triglycerides associated with an intake of 30 g of alcohol a day should reduce risk of coronary disease by 24.7% Alcohol intake may be causally related to lower risk of coronary heart disease through changes in lipids and haemostatic factors

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmj.319.7224.1523

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Excess alcohol consumption, particularly in individuals with pre-existing hypertriglyceridemia, is associated with marked triglyceride elevation, often ≥250 mg/dL.

    “Excess alcohol consumption, particularly in individuals with pre-existing hypertriglyceridemia, is associated with marked triglyceride elevation, often ≥250 mg/dL, and can precipitate hypertriglyceridemic pancreatitis (93,98).”

    From 2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia (2021) · cites this paper as [93]

    The Triglycerides section (page unavailable) reports that alcohol intake increased triglycerides, but by an average of only 5.69 mg/dL at 30 g/day. Alcohol and other factors (page unavailable) says the studies were mostly in young, healthy people with low baseline triglycerides. The paper does not establish marked elevations of ≥250 mg/dL with excess consumption, particularly in people with pre-existing hypertriglyceridemia. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • Alcohol consumption of 1 ounce per day is estimated to correspond to a 5% to 10% higher concentration of triglycerides in drinkers versus nondrinkers.

    “Alcohol consumption of 1 ounce per day is estimated to correspond to a 5% to 10% higher concentration of triglycerides in drinkers versus nondrinkers (93,94).”
  • Excess alcohol consumption can precipitate hypertriglyceridemic pancreatitis.

    “Excess alcohol consumption, particularly in individuals with pre-existing hypertriglyceridemia, is associated with marked triglyceride elevation, often ≥250 mg/dL, and can precipitate hypertriglyceridemic pancreatitis (93,98).”

    From 2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia (2021) · cites this paper as [93]

    The Triglycerides section reports a small increase in triglycerides with moderate alcohol intake. A search of our copy for pancreatitis and excessive alcohol consumption found no passage addressing whether excess drinking can precipitate hypertriglyceridemic pancreatitis. No page number was available for the indexed passage. (LLM, conf=0.74)

    Experimental — accuracy not yet measured
  • Red yeast rice preparations providing 5-10 mg monacolin K once daily produce a clinically relevant cholesterol reduction of up to 20%.

    “A clinically relevant hypocholesterolaemic effect (up to a 20% reduction) has been observed with RYR preparations providing an o.d. [once daily (omni die)] dose of 5-10 mg monacolin K [145].”
  • Alcohol intake has a major negative impact on triglyceride levels; in individuals with hypertriglyceridaemia even a small amount can raise triglycerides, while in the general population detrimental effects occur only above moderate consumption (10-30 g/day).

    “Alcohol intake has a major negative impact on TG levels.While in individuals with HTG even a small amount of alcohol can induce a further elevation of TG concentrations, in the general population alcohol exerts detrimental effects on TG levels only if the intake exceeds what is considered a moderate consumption (up to 1-2 drinks/day corresponding to 10-30 g/day).74”

    From ESC/EAS Guidelines for the management of dyslipidaemias (2011) · cites this paper as [74]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Vitelli LL, Folsom AR, Shahar E, Winkhart SP, Shirnakawa T, Stevens J, et al. Association of dietary composition with fasting serum insulin level-the ARIC study. Nutr Metab Cardiovasc Dis 1996;6:194-202.
  2. Department of Health. Interdepartmental working group. Sensible drink- ing. Wetherby: DoH, 1995. (Accepted 7 September 1999) Papers 1528 BMJ VOLUME 319 11 DECEMBER 1999 www.bmj.com on 10 August 2023 by guest. Protected by copyright. http://www.bmj.com/ BMJ: first published as 10.1136/bmj.319.7224.1523 on 11 December 1999. Downloaded from

Cited by

Sorted by citations

Authors
Rimm, E. B., Williams, P., Fosher, K., Criqui, M., & Stampfer, M. J.
Affiliations
Harvard University (US)
Corresponding author
Rimm, E. B
Venue
BMJ
Publisher
BMJ
Published
1999-12-11
Volume
319
Issue
7224
Pages
1523-1528
ISSN
  • 0007-1447 (ISSN-L)
  • 0959-8138
  • 1468-5833
OpenAlex
W1969728057
Cited by
1,360
References
57
Citations by year
2026: 19 · 2025: 16 · 2024: 26 · 2023: 24 · 2022: 26 · 2021: 50 · 2020: 29 · 2019: 45 · 2018: 50 · 2017: 48 · 2016: 42 · 2015: 52 · 2014: 47 · 2013: 68 · 2012: 83
FWCI
6.55
Type
journal article
Language
en
Open access
Locations
  • BMJ (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
Keywords
moderate drinking, coronary heart disease risk, HDL cholesterol, apolipoprotein A-I, triglycerides, fibrinogen, hemostatic factors, tissue plasminogen activator, alcohol dose-response, cardiovascular risk markers, ethanol
MeSH terms
Alcohol Drinking, Cardiovascular Diseases, Female, Homeostasis, Humans, Lipids, Cholesterol, HDL, Male, Prospective Studies, Risk Factors, Triglycerides, Biomarkers, Apolipoprotein A-I

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review